We're committed to helping the healthcare community realize the benefits of advanced diagnostic technologies to enable better patient care and reduce healthcare costs. Our rapid testing products enable our customers to decentralize testing and enhance their ability to deliver critical diagnostic results. Our quality products deliver trusted results which translate to better diagnostic decisions.
Nanogen's development efforts ensure that our rapid testing products deliver rapid, reliable results, with products that are always easy to use. In order to provide a better customer experience, we offer comprehensive support to our customers including on-site training, assistance with trouble-shooting, optimized protocols, assisted correlation studies, and an implementation plan customized to your needs.
We are involved with leading industry organizations in setting Point of Care Standards and in creating innovative leading-edge rapid testing products to advance the Point of Care industry. Nanogen currently has active roles in The Society of Chest Pain Centers and The Emergency Nurses Association and was awarded a contract from the U.S. Centers for Disease Control and Prevention (CDC) to develop a unique multi-analyte Point of Care diagnostic assay for Influenza.
- The Society of Chest Pain Centers: http://www.scpcp.org/
- Emergency Nurses Association: http://www.ena.org/
- U.S. Centers for Disease Control and Prevention (CDC): http://www.cdc.gov/